{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:54:41Z","timestamp":1791230081037,"version":"4.1.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2025-00556031"],"award-info":[{"award-number":["RS-2025-00556031"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2023-00219399"],"award-info":[{"award-number":["RS-2023-00219399"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cysteine (Cys) posttranslational modifications play a critical role in regulating protein function, cellular signaling and redox homeostasis in various physiological and pathological conditions. Sulfiredoxin-1 (SRXN1) has emerged as a key regulator of protein redox homeostasis through its involvement in Cys sulfinylation. However, the role of SRXN1 in the pathogenesis of diseases and its therapeutic implications have yet to be fully explored. Beyond its classical function in reactive oxygen species detoxification, SRXN1 also modulates redox-sensitive signaling pathways that govern inflammation, apoptosis and cell survival, making it an essential component of cellular defense against oxidative stress-related damage. Here we highlight the significance of SRXN1 in regulating Cys sulfinylation across a broad spectrum of liver diseases. Furthermore, we emphasize the critical role of SRXN1 in regulating oxidative stress and cellular signaling through its interaction and desulfinylation of target or substrate proteins, both of which are crucial to maintaining cellular function under pathological conditions. Finally, we discuss the potential therapeutic implications of targeting SRXN1 in disease contexts where oxidative stress exacerbates pathological processes. A deeper understanding of SRXN1-mediated redox regulation may offer a novel therapeutic avenue to mitigate Cys oxidation and improve clinical outcomes in various liver disease contexts.<\/jats:p>","DOI":"10.1038\/s12276-025-01563-5","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T07:42:50Z","timestamp":1761205370000},"page":"2226-2233","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Redox regulation by sulfiredoxin-1: bridging cysteine oxidation and liver disease therapeutics"],"prefix":"10.1038","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-1219-6967","authenticated-orcid":false,"given":"Jong-Won","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyun","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7810-3482","authenticated-orcid":false,"given":"Donovan","family":"Whitfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4010-9628","authenticated-orcid":false,"given":"Gu Seob","family":"Roh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3967-155X","authenticated-orcid":false,"given":"Wen","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,23]]},"reference":[{"key":"1563_CR1","volume":"2017","author":"G Pizzino","year":"2017","unstructured":"Pizzino, G. et al. Oxidative stress: harms and benefits for human health. Oxid. Med. Cell Longev. 2017, 8416763 (2017).","journal-title":"Oxid. Med. Cell Longev."},{"key":"1563_CR2","doi-asserted-by":"crossref","first-page":"1221520","DOI":"10.3389\/fendo.2023.1221520","volume":"14","author":"B Holendova","year":"2023","unstructured":"Holendova, B. & Plecita-Hlavata, L. Cysteine residues in signal transduction and its relevance in pancreatic beta cells. Front. Endocrinol. 14, 1221520 (2023).","journal-title":"Front. Endocrinol."},{"key":"1563_CR3","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41392-024-02095-6","volume":"10","author":"B Li","year":"2025","unstructured":"Li, B. et al. Redox regulation: mechanisms, biology and therapeutic targets in diseases. Signal Transduct. Target. Ther. 10, 72 (2025).","journal-title":"Signal Transduct. Target. Ther."},{"key":"1563_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.acr.2024.04.008","volume":"164","author":"V Marensi","year":"2024","unstructured":"Marensi, V. Redox, cysteines, and kinases\u2014a triad sustaining myeloid leukemia. Adv. Cancer Res. 164, 1\u201368 (2024).","journal-title":"Adv. Cancer Res."},{"key":"1563_CR5","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.freeradbiomed.2012.05.020","volume":"53","author":"W Jeong","year":"2012","unstructured":"Jeong, W., Bae, S. H., Toledano, M. B. & Rhee, S. G. Role of sulfiredoxin as a regulator of peroxiredoxin function and regulation of its expression. Free Radic. Biol. Med. 53, 447\u2013456 (2012).","journal-title":"Free Radic. Biol. Med."},{"key":"1563_CR6","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1038\/s41589-018-0116-2","volume":"14","author":"S Akter","year":"2018","unstructured":"Akter, S. et al. Chemical proteomics reveals new targets of cysteine sulfinic acid reductase. Nat. Chem. Biol. 14, 995\u20131004 (2018).","journal-title":"Nat. Chem. Biol."},{"key":"1563_CR7","volume":"29","author":"H Wang","year":"2025","unstructured":"Wang, H. et al. Srxn1 overexpression protect against cardiac remodelling by inhibiting oxidative stress and inflammation. J. Cell Mol. Med. 29, e70432 (2025).","journal-title":"J. Cell Mol. Med."},{"key":"1563_CR8","volume":"141","author":"Z Zhang","year":"2024","unstructured":"Zhang, Z. et al. Sulfiredoxin 1 ameliorates doxorubicin-induced cardiotoxicity by suppressing oxidative stress and inflammation via the Sirt1\/NLRP3 pathway. Int. Immunopharmacol. 141, 113010 (2024).","journal-title":"Int. Immunopharmacol."},{"key":"1563_CR9","volume":"187","author":"KR Hahn","year":"2025","unstructured":"Hahn, K. R. et al. Therapeutic potential of cell-permeable PEP-1\u2013Srxn1 in mitigating oxidative and ischemic damage in the hippocampus. Neurochem. Int. 187, 105988 (2025).","journal-title":"Neurochem. Int."},{"key":"1563_CR10","volume":"12","author":"J He","year":"2021","unstructured":"He, J. et al. Sulfiredoxin-1 attenuates injury and inflammation in acute pancreatitis through the ROS\/ER stress\/Cathepsin B axis. Cell Death Dis. 12, 626 (2021).","journal-title":"Cell Death Dis."},{"key":"1563_CR11","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.canlet.2015.07.002","volume":"366","author":"M Mishra","year":"2015","unstructured":"Mishra, M., Jiang, H., Wu, L., Chawsheen, H. A. & Wei, Q. The sulfiredoxin\u2013peroxiredoxin (Srx\u2013Prx) axis in cell signal transduction and cancer development. Cancer Lett. 366, 150\u2013159 (2015).","journal-title":"Cancer Lett."},{"key":"1563_CR12","doi-asserted-by":"crossref","first-page":"4322","DOI":"10.1021\/bi00067a022","volume":"32","author":"J Clarke","year":"1993","unstructured":"Clarke, J. & Fersht, A. R. Engineered disulfide bonds as probes of the folding pathway of barnase: increasing the stability of proteins against the rate of denaturation. Biochemistry 32, 4322\u20134329 (1993).","journal-title":"Biochemistry"},{"key":"1563_CR13","doi-asserted-by":"crossref","first-page":"e16398","DOI":"10.7717\/peerj.16398","volume":"11","author":"M Na","year":"2023","unstructured":"Na, M., Yang, X., Deng, Y., Yin, Z. & Li, M. Endoplasmic reticulum stress in the pathogenesis of alcoholic liver disease. PeerJ 11, e16398 (2023).","journal-title":"PeerJ"},{"key":"1563_CR14","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1089\/met.2024.0013","volume":"22","author":"F Sak","year":"2024","unstructured":"Sak, F., Sengul, F. & Vatansev, H. The role of endoplasmic reticulum stress in metabolic diseases. Metab. Syndr. Relat. Disord. 22, 487\u2013493 (2024).","journal-title":"Metab. Syndr. Relat. Disord."},{"key":"1563_CR15","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1089\/ars.2009.2466","volume":"11","author":"F Hatahet","year":"2009","unstructured":"Hatahet, F. & Ruddock, L. W. Protein disulfide isomerase: a critical evaluation of its function in disulfide bond formation. Antioxid. Redox Signal 11, 2807\u20132850 (2009).","journal-title":"Antioxid. Redox Signal"},{"key":"1563_CR16","doi-asserted-by":"crossref","first-page":"5647","DOI":"10.1021\/bi00476a001","volume":"29","author":"BL Vallee","year":"1990","unstructured":"Vallee, B. L. & Auld, D. S. Zinc coordination, function, and structure of zinc enzymes and other proteins. Biochemistry 29, 5647\u20135659 (1990).","journal-title":"Biochemistry"},{"key":"1563_CR17","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1126\/science.277.5326.653","volume":"277","author":"H Beinert","year":"1997","unstructured":"Beinert, H., Holm, R. H. & M\u00fcnck, E. Iron\u2013sulfur clusters: nature\u2019s modular, multipurpose structures. Science 277, 653\u2013659 (1997).","journal-title":"Science"},{"key":"1563_CR18","doi-asserted-by":"crossref","unstructured":"Percio, A. et al. Oxidative cysteine post translational modifications drive the redox code underlying neurodegeneration and amyotrophic lateral sclerosis. Antioxidants 13, 883 (2024).","DOI":"10.3390\/antiox13080883"},{"key":"1563_CR19","doi-asserted-by":"crossref","first-page":"103332","DOI":"10.1016\/j.redox.2024.103332","volume":"76","author":"B Mu","year":"2024","unstructured":"Mu, B., Zeng, Y., Luo, L. & Wang, K. Oxidative stress-mediated protein sulfenylation in human diseases: past, present, and future. Redox Biol. 76, 103332 (2024).","journal-title":"Redox Biol."},{"key":"1563_CR20","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1111\/j.1742-4658.2009.06985.x","volume":"276","author":"A Hall","year":"2009","unstructured":"Hall, A., Karplus, P. A. & Poole, L. B. Typical 2-Cys peroxiredoxins\u2014structures, mechanisms and functions. FEBS J. 276, 2469\u20132477 (2009).","journal-title":"FEBS J."},{"key":"1563_CR21","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1126\/science.1080273","volume":"300","author":"HA Woo","year":"2003","unstructured":"Woo, H. A. et al. Reversing the inactivation of peroxiredoxins caused by cysteine sulfinic acid formation. Science 300, 653\u2013656 (2003).","journal-title":"Science"},{"key":"1563_CR22","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/nature02075","volume":"425","author":"B Biteau","year":"2003","unstructured":"Biteau, B., Labarre, J. & Toledano, M. B. ATP-dependent reduction of cysteine-sulphinic acid by S. cerevisiae sulphiredoxin. Nature 425, 980\u2013984 (2003).","journal-title":"Nature"},{"key":"1563_CR23","doi-asserted-by":"crossref","first-page":"50994","DOI":"10.1074\/jbc.M409482200","volume":"279","author":"TS Chang","year":"2004","unstructured":"Chang, T. S. et al. Characterization of mammalian sulfiredoxin and its reactivation of hyperoxidized peroxiredoxin through reduction of cysteine sulfinic acid in the active site to cysteine. J. Biol. Chem. 279, 50994\u201351001 (2004).","journal-title":"J. Biol. Chem."},{"key":"1563_CR24","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1074\/jbc.C400496200","volume":"280","author":"HA Woo","year":"2005","unstructured":"Woo, H. A. et al. Reduction of cysteine sulfinic acid by sulfiredoxin is specific to 2-Cys peroxiredoxins. J. Biol. Chem. 280, 3125\u20133128 (2005).","journal-title":"J. Biol. Chem."},{"key":"1563_CR25","doi-asserted-by":"crossref","first-page":"23846","DOI":"10.1074\/jbc.M803244200","volume":"283","author":"TJ J\u00f6nsson","year":"2008","unstructured":"J\u00f6nsson, T. J., Murray, M. S., Johnson, L. C. & Lowther, W. T. Reduction of cysteine sulfinic acid in peroxiredoxin by sulfiredoxin proceeds directly through a sulfinic phosphoryl ester intermediate. J. Biol. Chem. 283, 23846\u201323851 (2008).","journal-title":"J. Biol. Chem."},{"key":"1563_CR26","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.redox.2018.05.002","volume":"17","author":"A Raghunath","year":"2018","unstructured":"Raghunath, A. et al. Antioxidant response elements: discovery, classes, regulation and potential applications. Redox Biol. 17, 297\u2013314 (2018).","journal-title":"Redox Biol."},{"key":"1563_CR27","doi-asserted-by":"crossref","first-page":"5205","DOI":"10.1073\/pnas.0700898104","volume":"104","author":"Y Liu","year":"2007","unstructured":"Liu, Y. et al. A genomic screen for activators of the antioxidant response element. Proc. Natl Acad. Sci. USA 104, 5205\u20135210 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1563_CR28","doi-asserted-by":"crossref","unstructured":"Hine, C. M. & Mitchell, J. R. NRF2 and the phase II response in acute stress resistance induced by dietary restriction. J. Clin. Exp. Pathol. S4, 7329 (2012).","DOI":"10.4172\/2161-0681.S4-004"},{"key":"1563_CR29","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s10059-009-0050-y","volume":"27","author":"FX Soriano","year":"2009","unstructured":"Soriano, F. X. et al. Transcriptional regulation of the AP-1 and Nrf2 target gene sulfiredoxin. Mol. Cells 27, 279\u2013282 (2009).","journal-title":"Mol. Cells"},{"key":"1563_CR30","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.freeradbiomed.2008.10.026","volume":"46","author":"A Singh","year":"2009","unstructured":"Singh, A. et al. Nrf2-dependent sulfiredoxin-1 expression protects against cigarette smoke-induced oxidative stress in lungs. Free Radic. Biol. Med. 46, 376\u2013386 (2009).","journal-title":"Free Radic. Biol. Med."},{"key":"1563_CR31","doi-asserted-by":"crossref","unstructured":"Saha, S., Buttari, B., Panieri, E., Profumo, E. & Saso, L. An overview of Nrf2 signaling pathway and its role in inflammation. Molecules 25, 5474 (2020).","DOI":"10.3390\/molecules25225474"},{"key":"1563_CR32","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00204-018-2353-2","volume":"93","author":"LJM Bischoff","year":"2019","unstructured":"Bischoff, L. J. M. et al. A systematic analysis of Nrf2 pathway activation dynamics during repeated xenobiotic exposure. Arch. Toxicol. 93, 435\u2013451 (2019).","journal-title":"Arch. Toxicol."},{"key":"1563_CR33","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ccell.2018.03.022","volume":"34","author":"M Rojo de la Vega","year":"2018","unstructured":"Rojo de la Vega, M., Chapman, E. & Zhang, D. D. NRF2 and the hallmarks of cancer. Cancer Cell 34, 21\u201343 (2018).","journal-title":"Cancer Cell"},{"key":"1563_CR34","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.tibs.2014.02.002","volume":"39","author":"JD Hayes","year":"2014","unstructured":"Hayes, J. D. & Dinkova-Kostova, A. T. The Nrf2 regulatory network provides an interface between redox and intermediary metabolism. Trends Biochem. Sci. 39, 199\u2013218 (2014).","journal-title":"Trends Biochem. Sci."},{"key":"1563_CR35","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40164-020-00197-9","volume":"10","author":"Z Wu","year":"2021","unstructured":"Wu, Z., Nicoll, M. & Ingham, R. J. AP-1 family transcription factors: a diverse family of proteins that regulate varied cellular activities in classical hodgkin lymphoma and ALK+\u2009ALCL. Exp. Hematol. Oncol. 10, 4 (2021).","journal-title":"Exp. Hematol. Oncol."},{"key":"1563_CR36","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0955-0674(97)80068-3","volume":"9","author":"M Karin","year":"1997","unstructured":"Karin, M., Liu, Z. & Zandi, E. AP-1 function and regulation. Curr. Opin. Cell Biol. 9, 240\u2013246 (1997).","journal-title":"Curr. Opin. Cell Biol."},{"key":"1563_CR37","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0168-9525(90)90081-G","volume":"6","author":"EB Ziff","year":"1990","unstructured":"Ziff, E. B. Transcription factors: a new family gathers at the cAMP response site. Trends Genet. 6, 69\u201372 (1990).","journal-title":"Trends Genet."},{"key":"1563_CR38","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1073\/pnas.88.9.3720","volume":"88","author":"T Hai","year":"1991","unstructured":"Hai, T. & Curran, T. Cross-family dimerization of transcription factors Fos\/Jun and ATF\/CREB alters DNA binding specificity. Proc. Natl Acad. Sci. USA 88, 3720\u20133724 (1991).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1563_CR39","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2199-8-54","volume":"8","author":"DA Glauser","year":"2007","unstructured":"Glauser, D. A., Brun, T., Gauthier, B. R. & Schlegel, W. Transcriptional response of pancreatic beta cells to metabolic stimulation: large scale identification of immediate-early and secondary response genes. BMC Mol. Biol. 8, 54 (2007).","journal-title":"BMC Mol. Biol."},{"key":"1563_CR40","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/nn2071","volume":"11","author":"S Papadia","year":"2008","unstructured":"Papadia, S. et al. Synaptic NMDA receptor activity boosts intrinsic antioxidant defenses. Nat. Neurosci. 11, 476\u2013487 (2008).","journal-title":"Nat. Neurosci."},{"key":"1563_CR41","doi-asserted-by":"crossref","first-page":"19738","DOI":"10.1073\/pnas.0810676105","volume":"105","author":"Q Wei","year":"2008","unstructured":"Wei, Q., Jiang, H., Matthews, C. P. & Colburn, N. H. Sulfiredoxin is an AP-1 target gene that is required for transformation and shows elevated expression in human skin malignancies. Proc. Natl Acad. Sci. USA 105, 19738\u201319743 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1563_CR42","doi-asserted-by":"crossref","first-page":"6800","DOI":"10.1158\/0008-5472.CAN-06-0484","volume":"66","author":"VJ Findlay","year":"2006","unstructured":"Findlay, V. J. et al. A novel role for human sulfiredoxin in the reversal of glutathionylation. Cancer Res. 66, 6800\u20136806 (2006).","journal-title":"Cancer Res."},{"key":"1563_CR43","doi-asserted-by":"crossref","first-page":"E7564","DOI":"10.1073\/pnas.1608784113","volume":"113","author":"CR Sunico","year":"2016","unstructured":"Sunico, C. R. et al. Role of sulfiredoxin as a peroxiredoxin-2 denitrosylase in human iPSC-derived dopaminergic neurons. Proc. Natl Acad. Sci. USA 113, E7564\u2013e7571 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1563_CR44","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nmeth1100","volume":"4","author":"ES Witze","year":"2007","unstructured":"Witze, E. S., Old, W. M., Resing, K. A. & Ahn, N. G. Mapping protein post-translational modifications with mass spectrometry. Nat. Methods 4, 798\u2013806 (2007).","journal-title":"Nat. Methods"},{"key":"1563_CR45","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1021\/acschembio.5b00124","volume":"10","author":"M Lo Conte","year":"2015","unstructured":"Lo Conte, M., Lin, J., Wilson, M. A. & Carroll, K. S. A chemical approach for the detection of protein sulfinylation. ACS Chem. Biol. 10, 1825\u20131830 (2015).","journal-title":"ACS Chem. Biol."},{"key":"1563_CR46","doi-asserted-by":"crossref","first-page":"47361","DOI":"10.1074\/jbc.C300428200","volume":"278","author":"HA Woo","year":"2003","unstructured":"Woo, H. A. et al. Reversible oxidation of the active site cysteine of peroxiredoxins to cysteine sulfinic acid. Immunoblot detection with antibodies specific for the hyperoxidized cysteine-containing sequence. J. Biol. Chem. 278, 47361\u201347364 (2003).","journal-title":"J. Biol. Chem."},{"key":"1563_CR47","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103080","volume":"70","author":"J Yuan","year":"2024","unstructured":"Yuan, J. et al. DDAH1 recruits peroxiredoxin 1 and sulfiredoxin 1 to preserve its activity and regulate intracellular redox homeostasis. Redox Biol. 70, 103080 (2024).","journal-title":"Redox Biol."},{"key":"1563_CR48","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.mam.2007.09.004","volume":"29","author":"E Albano","year":"2008","unstructured":"Albano, E. Oxidative mechanisms in the pathogenesis of alcoholic liver disease. Mol. Asp. Med 29, 9\u201316 (2008).","journal-title":"Mol. Asp. Med"},{"key":"1563_CR49","doi-asserted-by":"crossref","first-page":"332","DOI":"10.4254\/wjh.v12.i7.332","volume":"12","author":"HK Tan","year":"2020","unstructured":"Tan, H. K., Yates, E., Lilly, K. & Dhanda, A. D. Oxidative stress in alcohol-related liver disease. World J. Hepatol. 12, 332\u2013349 (2020).","journal-title":"World J. Hepatol."},{"key":"1563_CR50","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1002\/hep.24104","volume":"53","author":"SH Bae","year":"2011","unstructured":"Bae, S. H. et al. Concerted action of sulfiredoxin and peroxiredoxin I protects against alcohol-induced oxidative injury in mouse liver. Hepatology 53, 945\u2013953 (2011).","journal-title":"Hepatology"},{"key":"1563_CR51","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/HEP.0000000000001133","volume":"82","author":"JW Kim","year":"2025","unstructured":"Kim, J. W. et al. The de-sulfinylation enzyme sulfiredoxin-1 attenuates hepatic stellate cell activation and liver fibrosis by modulating the PTPN12\u2013NLRP3 axis. Hepatology 82, 92\u2013109 (2025).","journal-title":"Hepatology"},{"key":"1563_CR52","doi-asserted-by":"crossref","first-page":"8318","DOI":"10.1002\/cam4.3430","volume":"9","author":"QW Rao","year":"2020","unstructured":"Rao, Q. W. et al. Sulfiredoxin-1 is a promising novel prognostic biomarker for hepatocellular carcinoma. Cancer Med. 9, 8318\u20138332 (2020).","journal-title":"Cancer Med."},{"key":"1563_CR53","volume":"441","author":"Q Rao","year":"2024","unstructured":"Rao, Q. et al. Sulfiredoxin-1 promotes the growth of hepatocellular carcinoma by inhibiting TFEB-mediated autophagy and lysosome biogenesis. Exp. Cell Res. 441, 114169 (2024).","journal-title":"Exp. Cell Res."},{"key":"1563_CR54","doi-asserted-by":"crossref","first-page":"10714","DOI":"10.1111\/jcmm.15693","volume":"24","author":"X Lv","year":"2020","unstructured":"Lv, X. et al. SRXN1 stimulates hepatocellular carcinoma tumorigenesis and metastasis through modulating ROS\/p65\/BTG2 signalling. J. Cell Mol. Med. 24, 10714\u201310729 (2020).","journal-title":"J. Cell Mol. Med."},{"key":"1563_CR55","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jmgm.2019.07.018","volume":"92","author":"M Kim","year":"2019","unstructured":"Kim, M., Kwon, J., Goo, J. I., Choi, Y. & Cho, A. E. Elucidation of the inhibition mechanism of sulfiredoxin using molecular modeling and development of its inhibitors. J. Mol. Graph Model 92, 208\u2013215 (2019).","journal-title":"J. Mol. Graph Model"},{"key":"1563_CR56","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.redox.2012.10.001","volume":"1","author":"E Kansanen","year":"2013","unstructured":"Kansanen, E., Kuosmanen, S. M., Leinonen, H. & Levonen, A. L. The Keap1\u2013Nrf2 pathway: Mechanisms of activation and dysregulation in cancer. Redox Biol. 1, 45\u201349 (2013).","journal-title":"Redox Biol."}],"container-title":["Experimental &amp; Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s12276-025-01563-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-025-01563-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-025-01563-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T23:03:36Z","timestamp":1762297416000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s12276-025-01563-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,23]]},"references-count":56,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["1563"],"URL":"https:\/\/doi.org\/10.1038\/s12276-025-01563-5","relation":{},"ISSN":["2092-6413"],"issn-type":[{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,23]]},"assertion":[{"value":"21 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}